Clinical trial
Impact of a Synbiotic Containing Fructo-oligosaccharides and Bifidobacteria on Stool Frequency and Biological Markers in Middle-aged Adults: a Randomized, Double-blind, Placebo-controlled Clinical Trial
NCT04283266 is registered in ClinicalTrials.gov with Vesale Pharmaceutica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of a Synbiotic Containing Fructo-oligosaccharides and Bifidobacteria on Stool Frequency and Biological Markers in Middle-aged Adults: a Randomized, Double-blind, Placebo-controlled Clinical Trial
- Lead sponsor
- Vesale Pharmaceutica
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 12, 2016
- Completion date
- January 31, 2019
- Enrollment
- 27 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.